These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2120204)

  • 1. New pharmacologic approaches to obsessive compulsive disorder.
    Insel TR
    J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].
    Flament MF
    Encephale; 1993; 19(2):75-81. PubMed ID: 8275900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
    Zohar J; Zohar-Kadouch RC; Kindler S
    Drugs; 1992 Feb; 43(2):210-8. PubMed ID: 1372219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA; Fineberg NA; Montgomery D
    Encephale; 1990; 16 Spec No():335-9. PubMed ID: 2209492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacotherapy of obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Price LH
    Pharmacopsychiatry; 1993 May; 26 Suppl 1():24-9. PubMed ID: 8378419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of obsessive-compulsive disorder.
    Zohar J; Insel TR
    J Affect Disord; 1987; 13(2):193-202. PubMed ID: 2960711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT; Insel TR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine as an antiobsessional agent.
    Goodman WK; Price LH; Rasmussen SA; Heninger GR; Charney DS
    Psychopharmacol Bull; 1989; 25(1):31-5. PubMed ID: 2505302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    Flament MF; Bisserbe JC
    J Clin Psychiatry; 1997; 58 Suppl 12():18-22. PubMed ID: 9393392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.